Next-Generation Biomanufacturing Market Analysis Reveals Key Trends in Continuous Upstream and Downstream Processing to 2034

Insight Analytics Pvt. Ltd. announces the release of a market assessment report on the "Global Next-Generation Biomanufacturing Market- by Medical Applications (Monoclonal Antibodies, Hormones, Vaccines, Recombinant Proteins and Other Applications), Products (Continuous Upstream Biomanufacturing Products, Single-Use Upstream Biomanufacturing Products and Downstream Biomanufacturing Products), Workflow (Upstream Biomanufacturing and Downstream Biomanufacturing), End-Users (Biopharmaceutical Companies, CMOs (Contract manufacturing organizations)/CDMOs (Contract Development and Manufacturing Organization) and Research Institutions), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."

According to the latest research by Insight Analytics, the global Next-Generation Biomanufacturing market was valued at 24.9 Billion in 2024. It is expected to reach 80.0 Billion by the year 2034, with a CAGR of 12.6% during a forecast period of 2025-2034.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1261

The rapid expansion of the biopharmaceutical industry is a primary catalyst for the growth of the next-generation biomanufacturing market. This sector is increasingly defined by the integration of advanced production methodologies for the development of biologically derived products. Leveraging cutting-edge technologies-including artificial intelligence (AI), machine learning (ML), and augmented reality (AR)-these next-generation approaches offer enhanced efficiency, seamless operations, and improved product quality when compared to conventional biomanufacturing techniques.

Several factors are expected to substantially contribute to market growth, including the presence of robust healthcare infrastructures, advancements in bioprocessing systems, increased governmental support, the rising prevalence of chronic and genetic disorders, a growing aging population, and the widespread availability of advanced medical technologies. Owing to the complex requirements associated with biologics research, development, and production, biopharmaceutical organizations are increasingly investing in next-generation manufacturing solutions to achieve greater operational efficiency and product consistency. This trend is expected to accelerate market growth in the years ahead.

However, the adoption of these advanced technologies may be hindered by several challenges, notably the limited availability of skilled professionals and the complexity of implementation and operation associated with next-generation systems.

Regionally, North America is expected to maintain a dominant position in the market, supported by the presence of leading biopharmaceutical firms, high rates of technology adoption, and a well-established life sciences research ecosystem. Europe is also projected to exhibit substantial growth, driven by expanding technological integration and increasing healthcare demands in key emerging economies such as China and India.

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-04

Major market players operating in the Next-Generation Biomanufacturing market include Applikon Biotechnology BV (Netherlands), bbi-biotech GmbH (Germany), Danaher Corporation (US), Eppendorf AG (Germany), Esco Group of Companies (US), GEA Group Aktiengesellschaft (Germany), Meissner Filtration Products, Inc. (US), Merck KGaA (Germany), PBS Biotech, Inc. (US), Pierre Guérin (France), Sartorius AG (Germany), Shanghai Bailun Biotechnology Co. Ltd. (China), Solaris Biotechnology Srl. (Italy), Thermo Fisher Scientific Inc. (US), ZETA GmbH (Austria), and others.

Recent collaborations and agreements in the market:
In August 2021, PBS Biotech (US) raised its most significant round of funding from BroadOak Capital Partners to develop its product offerings and capabilities. The funds will be utilized to increase PBS's product offerings and capabilities and address the demand for cell therapies.
In February 2021, Merck (Germany) collaborated with Alteogen, Inc. (South Korea), which provides late-stage CDMO services via Merck's BioReliance end-to-end solutions. Alteogen chose Merck to develop and manufacture recombinant biologics for developing and clinical testing next-generation monoclonal antibody medicines.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/1261

Market Segments
Global Next-Generation Biomanufacturing Market, by Medical Applications, 2022-2030 (Value US$ Mn)
• Monoclonal Antibodies
• Hormones
• Vaccines
• Recombinant Proteins
• Other Applications
Global Next-Generation Biomanufacturing Market, by Products, 2022-2030 (Value US$ Mn)
• Continuous Upstream Biomanufacturing Products
• Single-Use Upstream Biomanufacturing Products
• Downstream Biomanufacturing Products
Global Next-Generation Biomanufacturing Market, by Workflow, 2022-2030 (Value US$ Mn)
• Upstream Biomanufacturing
• Downstream Biomanufacturing
Global Next-Generation Biomanufacturing Market, by End-Users, 2022-2030 (Value US$ Mn)
• Biopharmaceutical Companies
• CMOs (Contract manufacturing organizations)/CDMOs (Contract Development and Manufacturing organizations)
• Research Institutions
Global Next-Generation Biomanufacturing Market, by Region, 2022-2030 (Value US$ Mn)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
North America Next-Generation Biomanufacturing Market, by Country, 2022-2030 (Value US$ Mn)
• U.S.
• Canada
Europe Next-Generation Biomanufacturing Market, by Country, 2022-2030 (Value US$ Mn)
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia Pacific Next-Generation Biomanufacturing Market, by Country, 2022-2030 (Value US$ Mn)
• India
• China
• Japan
• South Korea
• Australia & New Zealand
Latin America Next-Generation Biomanufacturing Market, by Country, 2022-2030 (Value US$ Mn)
• Brazil
• Mexico
• Rest of Latin America
Middle East & Africa Next-Generation Biomanufacturing Market, by Country, 2022-2030 (Value US$ Mn)
• GCC Countries
• South Africa
• Rest of Middle East & Africa

Why should buy this report:
 To receive a comprehensive analysis of the prospects for the global Next-Generation Biomanufacturing market
 To receive an industry overview and future trends in the Next-Generation Biomanufacturing market
 To analyze the Next-Generation Biomanufacturing market drivers and challenges
 To get information on the Next-Generation Biomanufacturing market value (US$Mn) forecast to 2030
 Significant investments, mergers & acquisitions in the Next-Generation Biomanufacturing market industry

Read Overview Report- https://www.insightaceanalytic.com/report/global-next-generation-biomanufacturing-market-/1261

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 607 400-7072
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.